DE602005007205D1 - Gastroretentive Zusammensetzungen und Verfahren zur Herstellung - Google Patents

Gastroretentive Zusammensetzungen und Verfahren zur Herstellung

Info

Publication number
DE602005007205D1
DE602005007205D1 DE602005007205T DE602005007205T DE602005007205D1 DE 602005007205 D1 DE602005007205 D1 DE 602005007205D1 DE 602005007205 T DE602005007205 T DE 602005007205T DE 602005007205 T DE602005007205 T DE 602005007205T DE 602005007205 D1 DE602005007205 D1 DE 602005007205D1
Authority
DE
Germany
Prior art keywords
preparation
methods
gastroretentive compositions
gastroretentive
formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005007205T
Other languages
English (en)
Inventor
Mahendra Chaudhari
Chandwani
Rajashree Bhalchan Yelegaonkar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ethypharm SAS
Original Assignee
Ethypharm SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethypharm SAS filed Critical Ethypharm SAS
Publication of DE602005007205D1 publication Critical patent/DE602005007205D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A61K9/2826—Sugars or sugar alcohols, e.g. sucrose; Derivatives thereof
DE602005007205T 2005-07-19 2005-07-19 Gastroretentive Zusammensetzungen und Verfahren zur Herstellung Active DE602005007205D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05291542A EP1745775B1 (de) 2005-07-19 2005-07-19 Gastroretentive Zusammensetzungen und Verfahren zur Herstellung

Publications (1)

Publication Number Publication Date
DE602005007205D1 true DE602005007205D1 (de) 2008-07-10

Family

ID=35517256

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005007205T Active DE602005007205D1 (de) 2005-07-19 2005-07-19 Gastroretentive Zusammensetzungen und Verfahren zur Herstellung

Country Status (13)

Country Link
US (1) US9629800B2 (de)
EP (2) EP1745775B1 (de)
JP (1) JP5199084B2 (de)
KR (1) KR101367814B1 (de)
CN (1) CN101237858B (de)
AT (1) ATE396710T1 (de)
AU (1) AU2006271314B2 (de)
BR (1) BRPI0612901B8 (de)
CA (1) CA2616081C (de)
DE (1) DE602005007205D1 (de)
HK (1) HK1122729A1 (de)
RU (1) RU2376983C2 (de)
WO (1) WO2007010400A2 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080076382A (ko) * 2007-02-15 2008-08-20 (주)아모레퍼시픽 실로스타졸의 제어방출 제제 및 그 제조방법
EP2346351B1 (de) 2008-09-22 2019-07-03 Rubicon Research Private Limited Zusammensetzungen mit verzögertem durchgang durch den magen-darm-trakt
FR2945947B1 (fr) 2009-05-29 2011-07-29 Flamel Tech Sa Compositions pharmaceutiques flottantes a liberation controlee
JP5594484B2 (ja) 2009-07-06 2014-09-24 杏林製薬株式会社 中空構造を有する錠剤
EP2361615A1 (de) 2010-02-19 2011-08-31 Alfred E. Tiefenbacher GmbH & Co. KG Tablette mit verlängerter Dipyridamolfreisetzung
EP2544666A2 (de) 2010-03-09 2013-01-16 Council of Scientific and Industrial Research Gastroretentive retard-zusammensetzung eines therapeutikums
AU2011237122B2 (en) * 2010-03-31 2014-06-12 Mochida Pharmaceutical Co., Ltd. Easily dosable solid preparation
CN101919817B (zh) * 2010-07-23 2012-05-30 山东齐都药业有限公司 一种拉呋替丁胃内滞留控制释放组合物
CA2847614C (en) 2011-09-30 2018-10-23 Mochida Pharmaceutical Co., Ltd. Easily dosable solid preparation
DE102012102414A1 (de) 2012-03-21 2013-10-10 Michael Dittgen Pharmazeutische Zusammensetzung für die einmal tägliche Anwendung antidiabetischer Arzneimittel wie Metformin mit Zwei-Puls-Freisetzung
WO2013168179A2 (en) * 2012-04-03 2013-11-14 Rubicon Research Private Limited Controlled release pharmaceutical formulations of antiviral agents
CN103110601B (zh) * 2013-02-04 2014-10-29 成都恒瑞制药有限公司 一种格列齐特胃漂浮片及其制备方法
FR3014692B1 (fr) * 2013-12-18 2016-01-29 Ethypharm Sa Compositions pharmaceutiques orales a retention gastrique.
TWI732337B (zh) * 2014-06-20 2021-07-01 美商梅琳塔有限責任公司 醫藥組成物及其用途
KR102414503B1 (ko) 2016-03-17 2022-06-29 티오제네시스 테라퓨틱스, 인크. 시스테아민의 조절 방출을 위한 조성물 및 시스테아민 민감성 장애의 전신 치료
CN107184560B (zh) * 2017-06-03 2021-02-02 寿光富康制药有限公司 二甲双胍胃滞留片及制备方法
US11612576B2 (en) 2017-09-20 2023-03-28 Thiogenesis Therapeutics, Inc. Methods for the treatment of cysteamine sensitive disorders
WO2019126215A1 (en) 2017-12-18 2019-06-27 Tris Pharma, Inc. Ghb pharmaceutical compositions comprising a floating interpenetrating polymer network forming system
CA3086153A1 (en) * 2017-12-18 2019-06-27 Tris Pharma, Inc. Modified release drug powder composition comprising gastro-retentive raft forming systems having trigger pulse drug release
CN109602714B (zh) * 2018-12-29 2020-06-12 广东中润药物研发有限公司 一种利伐沙班胃滞留片及其制备方法
GB2599950A (en) * 2020-10-16 2022-04-20 Zentiva Ks Pharmaceutical compositions with low amounts of nitrosamine impurities and methods for producing the same
CN117042629A (zh) * 2021-01-13 2023-11-10 杜邦营养美国公司 胃滞留药物递送系统

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61148115A (ja) * 1984-12-21 1986-07-05 Tooa Eiyoo Kk 難溶性薬物の徐放性製剤及びその製造法
GB8618847D0 (en) * 1986-08-01 1986-09-10 Smith Kline French Lab Pharmaceutical formulations
FR2653337B1 (fr) * 1989-10-23 1992-02-07 Dow Corning Sa Element a liberation prolongee et procede pour le fabriquer.
US6635280B2 (en) 1997-06-06 2003-10-21 Depomed, Inc. Extending the duration of drug release within the stomach during the fed mode
WO1999007342A1 (en) * 1997-08-11 1999-02-18 Alza Corporation Prolonged release active agent dosage form adapted for gastric retention
IN186245B (de) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
BR9908911A (pt) * 1998-03-19 2001-10-02 Bristol Myers Squibb Co Sistema bifásico e processo de distribuição por liberação controlada de substâncias farmacêuticas de alta solubilidade
PL346798A1 (en) * 1998-09-14 2002-02-25 Ranbaxy Lab Ltd Orally administered controlled drug delivery system providing temporal and spatial control
US6635281B2 (en) * 1998-12-23 2003-10-21 Alza Corporation Gastric retaining oral liquid dosage form
US6797283B1 (en) 1998-12-23 2004-09-28 Alza Corporation Gastric retention dosage form having multiple layers
AU1881600A (en) * 1998-12-23 2000-07-31 Alza Corporation Dosage forms comprising porous particles
WO2001064183A1 (en) * 2000-03-03 2001-09-07 Ranbaxy Laboratories Limited Orally administered controlled delivery system for once daily administration of ciprofloxacin
RU2325152C2 (ru) * 2001-07-04 2008-05-27 Сан Фармасьютикл Индастриз Лимитид Удерживаемая в желудке система регулируемой доставки лекарственного средства
AU2002302890A1 (en) * 2002-02-04 2003-12-02 Ranbaxy Laboratories Limited Hydrodynamically balancing oral drug delivery system with biphasic release
GB0205253D0 (en) * 2002-03-06 2002-04-17 Univ Gent Immediate release pharmaceutical granule compositions and a continuous process for making them
US7157100B2 (en) 2002-06-04 2007-01-02 J.B. Chemicals & Pharmaceuticals Ltd. Pharmaceutical composition for controlled drug delivery system
WO2005060942A1 (en) * 2003-12-19 2005-07-07 Aurobindo Pharma Ltd Extended release pharmaceutical composition of metformin

Also Published As

Publication number Publication date
WO2007010400A2 (en) 2007-01-25
AU2006271314B2 (en) 2011-07-07
BRPI0612901B1 (pt) 2020-08-04
JP2009501777A (ja) 2009-01-22
CA2616081C (en) 2013-09-10
ATE396710T1 (de) 2008-06-15
KR20080048461A (ko) 2008-06-02
CN101237858B (zh) 2012-07-04
US9629800B2 (en) 2017-04-25
CN101237858A (zh) 2008-08-06
AU2006271314A1 (en) 2007-01-25
EP1904034A2 (de) 2008-04-02
HK1122729A1 (en) 2009-05-29
KR101367814B1 (ko) 2014-02-27
RU2376983C2 (ru) 2009-12-27
EP1745775B1 (de) 2008-05-28
RU2008106220A (ru) 2009-08-27
WO2007010400A3 (en) 2007-04-05
BRPI0612901A2 (pt) 2010-12-07
BRPI0612901B8 (pt) 2021-05-25
JP5199084B2 (ja) 2013-05-15
EP1745775A1 (de) 2007-01-24
US20080220060A1 (en) 2008-09-11
CA2616081A1 (en) 2007-01-25

Similar Documents

Publication Publication Date Title
DE602005007205D1 (de) Gastroretentive Zusammensetzungen und Verfahren zur Herstellung
LTC1856135I2 (lt) 2,4-pirimidindiamino junginių provaistai ir jų panaudojimas
EA200701065A1 (ru) Инъецируемые составы, содержащие нанодисперсный оланзапин
DK1896006T3 (da) Fremstillingmetode for entacapon-holdige granuler til orale doseringsformet
CY1114887T1 (el) Συνθεσεις και μεθοδοι παρασκευης συνθεσης
BRPI0710508B8 (pt) composição de pepticorpo terapêutico liofilizado estável, kit para preparar uma composição farmacêutica aquosa, e métodos para fabricar um pepticorpo terapêutico liofilizado e para preparar uma composição de pepticorpo terapêutico reconstituído
DE602005023877D1 (de) Verfahren zur herstellung von 7-alpha-alkylierte 19-norsteroide
CR8529A (es) Nueva forma cristalina v de la agomelatina, su procedimiento de preparacion y las composiciones farmaceuticas que la contiene
TW200730178A (en) Aerosol formulations for the inhalation of β-agonists
EP2832342A3 (de) Dentale Zusammensetzungen mit Calzium und Phosphor-freisetzendem Glass
ECSP099529A (es) Inhibidores de cinasa mapk/erk
UY29767A1 (es) Derivados de benzotiazolonas, procesos para su preparación, composiciones farmacéuticas que los contienen y aplicaciones
IL193024A0 (en) Levetiracetam formulations and methods for their manufacture
DE602006006658D1 (de) Verfahren zur herstellung von calciumzusammensetzungen im kontinuierlichen fliessbett
UA92894C2 (ru) Способ приготовления и применения композиции адсорбента фосфата, адсорбент фосфата, композиция адсорбента фосфата
NO20075111L (no) Farmasoytisk sammensetning
EA200900267A1 (ru) КОМПОЗИЦИЯ ДЛЯ АЭРОЗОЛЬНОЙ ИНГАЛЯЦИИ β-АГОНИСТОВ И СТЕРОИДОВ
DK1560812T3 (da) Aminocyclohexyletherforbindelser og anvendelser deraf
WO2007025146A3 (en) Balsalazide formulations and manufacture and use thereof
CY1112960T1 (el) Παραγωγα ουριας, μεθοδοι για την παρασκευη τους και χρησεις αυτων
DK1688146T3 (da) Fremstilling af aldesleukin til farmaceutisk anvendelse
WO2006091836A8 (en) Formulations of ladostigil tartrate
TW200716167A (en) Formulations and process for production of bordetella bronchiseptica P68 antigen and vaccines
DE602006015837D1 (de) Formulierungen von tipifarnib zur intravenösen verabreichung
HN2001000225A (es) Composicion blanqueante dental y procedimiento que emplea un agente blanqueante acido dicarboxilico

Legal Events

Date Code Title Description
8364 No opposition during term of opposition